TransMedics Group Balance Sheet Health
Financial Health criteria checks 3/6
TransMedics Group has a total shareholder equity of $137.2M and total debt of $506.2M, which brings its debt-to-equity ratio to 368.9%. Its total assets and total liabilities are $706.0M and $568.8M respectively. TransMedics Group's EBIT is $485.0K making its interest coverage ratio -0.3. It has cash and short-term investments of $394.8M.
Key information
368.9%
Debt to equity ratio
US$506.20m
Debt
| Interest coverage ratio | -0.3x |
| Cash | US$394.81m |
| Equity | US$137.20m |
| Total liabilities | US$568.85m |
| Total assets | US$706.05m |
Recent financial health updates
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16Is TransMedics Group (NASDAQ:TMDX) Weighed On By Its Debt Load?
Jun 12Recent updates
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16TransMedics: Game Changer Technology Will Boost Revenue Growth
Oct 20TransMedics Is A Buy Following Q2 FY22 Earnings Upside
Aug 03Is TransMedics Group (NASDAQ:TMDX) Weighed On By Its Debt Load?
Jun 12TransMedics - Impressive Transformation
May 20Industry Analysts Just Upgraded Their TransMedics Group, Inc. (NASDAQ:TMDX) Revenue Forecasts By 26%
May 08Financial Position Analysis
Short Term Liabilities: TMDX's short term assets ($510.7M) exceed its short term liabilities ($54.9M).
Long Term Liabilities: TMDX's short term assets ($510.7M) do not cover its long term liabilities ($513.9M).
Debt to Equity History and Analysis
Debt Level: TMDX's net debt to equity ratio (81.2%) is considered high.
Reducing Debt: TMDX had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TMDX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if TMDX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.